Rebecca Byam - Feb 20, 2024 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Stock symbol
HCWB
Transactions as of
Feb 20, 2024
Transactions value $
$1,065,000
Form type
4
Date filed
2/22/2024, 02:19 PM
Previous filing
Oct 23, 2023
Next filing
May 9, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Award $1.06M +761K +122.46% $1.40 1.38M Feb 20, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended.